AllantoinvsUrea

Allantoin (5-ureidohydantoin) stimulates cell proliferation and tissue regeneration by promoting fibroblast activity, keratinocyte proliferation, and extracellular matrix synthesis including collagen and glycosaminoglycans. It acts as a mild keratolytic by promoting the natural desquamation process—loosening corneocyte adhesion and facilitating shedding—without the irritation, pH disruption, or barrier compromise associated with alpha- or beta-hydroxy acids. Allantoin has anti-inflammatory properties through modulation of prostaglandin synthesis (inhibiting COX-2 and reducing PGE2) and may downregulate pro-inflammatory cytokines. Its moisturizing effect comes from increasing the water-binding capacity of the extracellular matrix and stratum corneum; it is highly soluble and forms hydrogen bonds with water. Allantoin also promotes wound epithelialization. Its safety profile—non-irritating, non-sensitizing, non-comedogenic—makes it suitable for compromised skin, post-procedure care, and infant formulations.

At low concentrations (<10%), urea acts as a humectant — small molecule (60 Da) absorbing into stratum corneum, drawing water via hydrogen bonding to carbonyl and amine groups. Part of endogenous NMF (filaggrin degradation products with amino acids, lactate), highly biocompatible. Integrates into corneocyte envelope, supports aquaporin-3 water transport. At higher concentrations (>10%), denatures keratin (K1, K10) by disrupting hydrogen bonds in alpha-helical structure and disulfide bridges in cornified envelope, causing corneodesmosome degradation and desquamation. Keratolytic via direct protein denaturation, not enzymatic. Dual mechanism — humectant at low dose, keratolytic at high — versatile for hydration and hyperkeratotic conditions (psoriasis, keratosis pilaris).